NCT07523477 Local Injection of Botulinium Toxin-A in Children With Dysfunctional Voiding or Refractory Nocturnal Eneuresis
| NCT ID | NCT07523477 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tanta University |
| Condition | Local Injection |
| Study Type | INTERVENTIONAL |
| Enrollment | 64 participants |
| Start Date | 2025-06-01 |
| Primary Completion | 2026-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 64 participants in total. It began in 2025-06-01 with a primary completion date of 2026-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to evaluate the outcome of botulinum toxin A (BTX-A) injection for management of children with : A-Dysfunctional voiding who are not responding to traditional treatment. B-Refractory nocturnal enuresis.
Eligibility Criteria
Inclusion Criteria: * Children \< 18 years. * Both sexes. * Patients with refractory nocturnal enuresis or dysfunctional voiding who are not responding to the traditional treatment. Exclusion Criteria: * Bleeding disorders. * Neuromusclar disorder(e.g.,Myasthenia gravis). * Patients who are not fit for anaesthesia. * Active urinary tract infection (UTI).
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07523477 clinical trial?
This trial is open to participants of all sexes, up to 18 Years, studying Local Injection. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07523477 currently recruiting?
Yes, NCT07523477 is actively recruiting participants. Contact the research team at Ahmed.m.shalaby97@gmail.com for enrollment information.
Where is the NCT07523477 trial being conducted?
This trial is being conducted at Tanta, Egypt.
Who is sponsoring the NCT07523477 clinical trial?
NCT07523477 is sponsored by Tanta University. The trial plans to enroll 64 participants.